FACBC Prostate Therapy Response

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 1, 2018

Study Completion Date

September 30, 2019

Conditions
Prostate Cancer
Interventions
DRUG

FACBC PET-CT

Anti-3-\[18F\]FACBC is an investigational positron emission tomography (PET) radiotracer being studied given intravenously prior to PET scan.

OTHER

MRI, CT, or Bone Scan

Conventional imaging such as a MRI, CT, or bone scan will be performed to correlate imaging findings.

Trial Locations (1)

30322

Emory University Hospital, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Blue Earth Diagnostics

INDUSTRY

collaborator

Nihon Medi-Physics Co., Ltd.

INDUSTRY

lead

Emory University

OTHER